wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36355098-15B4E26C-8F12-4D17-AC7C-119E359474C2
Q36355098-15B4E26C-8F12-4D17-AC7C-119E359474C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36355098-15B4E26C-8F12-4D17-AC7C-119E359474C2
Managing chronic myeloid leukemia patients intolerant to tyrosine kinase inhibitor therapy.
P2860
Q36355098-15B4E26C-8F12-4D17-AC7C-119E359474C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36355098-15B4E26C-8F12-4D17-AC7C-119E359474C2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2ee6fa58daf42e1d06bcd280815ad378f45f76d6
P2860
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia.